The Enterprise Value as of December 2025 (TTM) for Xbrane Biopharma AB (publ) (XBRANE.ST) is 31.80M

According to Xbrane Biopharma AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 31.80M. This represents a change of -92.69% compared to the average of 434.83M of the last 4 quarters.

Xbrane Biopharma AB (publ) (XBRANE.ST) Historical Enterprise Value (quarterly & annually)

How has XBRANE.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Xbrane Biopharma AB (publ) over the last ten years is 6.59B. The current 31.80M Enterprise Value has changed -51.78% with respect to the historical average. Over the past ten years (40 quarters), XBRANE.ST's Enterprise Value was at its highest in in the September 2021 quarter at 29.56B. The Enterprise Value was at its lowest in in the March 2024 quarter at 56.79M.

Xbrane Biopharma AB (publ) (XBRANE.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xbrane Biopharma AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xbrane Biopharma AB (publ) (XBRANE.ST) Average Enterprise Value

How has XBRANE.ST Enterprise Value performed in the past?

The current Enterprise Value of Xbrane Biopharma AB (publ) (XBRANE.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Xbrane Biopharma AB (publ) (XBRANE.ST) Enterprise Value vs. Peers

How is XBRANE.ST’s Enterprise Value compared to its peers?

Xbrane Biopharma AB (publ)’s Enterprise Value is less than Scandinavian ChemoTech AB (publ) (100.63M), less than Biovica International AB (publ) (109.21M), less than Nanologica AB (publ) (69.37M), less than Alzinova AB (publ) (171.41M), less than Active Biotech AB (publ) (50.10M), less than Biosergen AB (77.10M), less than SciBase Holding AB (publ) (121.64M), less than Neola Medical AB (publ) (65.57M), less than NextCell Pharma AB (37.36M), less than AcuCort AB (103.31M),

Build a custom stock screener for Xbrane Biopharma AB (publ) (XBRANE.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xbrane Biopharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xbrane Biopharma AB (publ) (XBRANE.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xbrane Biopharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.